Live Breaking News & Updates on Covaxin news

Stay informed with the latest breaking news from Covaxin news on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covaxin news and stay connected to the pulse of your community

'Misleading': India Rejects Claim that Covaxin was Rushed Through Trials Due to 'Political Pressure'

Millions of doses of Covaxin were exported to other countries under India’s ‘Vaccine Maitri’ initiative before the WHO withdrew permission in April this year... 17.11.2022, Sputnik International

India , Bharat , World-health-organization , Indian-council-of-medical-research , Central-drugs-standard-control-organisation , India-ministry-of-health , Family-welfare , Bharat-biotech , Indian-council , Medical-research , Emergency-use-authorization

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

Covaxin news: In April this year, the World health Organization said it confirmed the suspension of supply of Covaxin through UN procurement agencies and recommended that countries using the vaccine take action as appropriate.

India , Brazil , Brazilian , Bharat , Precisa-medicamentos , Envixia-pharmaceuticals , World-health-organization , Central-drugs-standard-control-organisation , Google-news , Image-source , Bharat-biotech , Covaxin-news

WHO panel likely to decide on Covaxin EUL today; here's what you need to know

Covaxin is developed by Hyderabad-based Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune (NIV).

Mexico , Australia , Philippines , India , Iran , Zimbabwe , Pune , Maharashtra , Nepal , Mauritius , Guyana , Australian

Covaxin shelf life extended up to 12 months bharat biotech covid19 vaccine CDSCO

covaxin, covaxin shelf life,india extends covaxin shelf life,covaxin 12 months shelf life,covaxin expiry date extended,covaxin shelf life extended,covaxin news,covaxin latest news,covaxin latest update

India , Bharat , Central-drugs-standard-control-organisation , Image-source , Bharat-biotech , Covaxin , Ovaxin-shelf-life , India-extends-covaxin-shelf-life , Covaxin-12-months-shelf-life , Covaxin-expiry-date-extended , Covaxin-shelf-life-extended

Bharat Biotech seeks international manufacturing partners for Covaxin

Covaxin, the company's home-grown Covid-19 vaccine approved for emergency use in India, is one of two shots driving the country's massive vaccination programme

India , Bharat-biotech , Bharat-biotech-covaxin , Bharat-biotech-covaxin-international-manufacturing , Bharat-biotech-international-manufacturing-partner , Bharat-biotech-international-production , Covaxin , Covaxin-news , Covaxin-international-production ,

After US market, Bharat Biotech ties up with Ocugen for Covaxin sale in Canada | India News

HYDERABAD: Indigenously developed Covid-19 vaccine Covaxin is now eyeing the Canadian market with Bharat Biotech and its US partner Ocugen extending their US pact for Covaxin to include Canada as well.
Bharat Biotech and Ocugen on Thursday said they have entered into an amendment to their co-development, supply, and commercialization agreement to expand Ocugen’s exclusive territory to commercialize Covaxin to also include Canada, in addition to its existing rights to commercialise Covaxin in the United States.
As part of this amended deal, just like the US, Ocugen will make an upfront payment and milestone payment upon first commercial sale in Canada to Bharat Biotech. Ocugen will get to retain 45% of the profits from Covaxin sales in Canada while Bharat Biotech will get 55% share of the profits.

United-states , Hyderabad , Andhra-pradesh , India , Canada , Bharat , Canadian , Shankar-musunuri , Krishna-ella , Bharat-biotech , Ndia-news , Ndia-news-today

Paediatric trials of Covaxin may begin in June | India News

HYDERABAD: Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on "All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter.
"I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year," informed Dr. Raches Ella as a response to a question from a participant.

Bangalore , Karnataka , India , Hyderabad , Andhra-pradesh , Brazil , Bharat , Pragnya-chigurupati , Uma-chigurupati , Raches-ella , Union-government , International-advocacy-head-dr-raches-ella-on

Covaxin trail on children: Paediatric trials of Covaxin may begin in June | India News

HYDERABAD: Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on "All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter.
"I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year," informed Dr. Raches Ella as a response to a question from a participant.

Bangalore , Karnataka , India , Hyderabad , Andhra-pradesh , Brazil , Bharat , Pragnya-chigurupati , Uma-chigurupati , Raches-ella , Union-government , International-advocacy-head-dr-raches-ella-on

Covaxin Phase 2-3 Clinical Trials for Age Group 2-18 Begins on June

Covaxin Phase 2-3 Clinical Trials for Age Group 2-18 Begins on June
Bharat Biotech's Covaxin will begin Phase 2 and 3 clinical trials in the age group of 2 to 18 years in June, according to sources at the Hyderabad-based vaccine manufacturer.
| 24 May 2021 1:11 PM GMT
Bharat Biotech's Covaxin will begin Phase 2 and 3 clinical trials in the age group of 2 to 18 years in June, according to sources at the Hyderabad-based vaccine manufacturer.
Covaxin is being used on adults in India's ongoing Covid-19 vaccination drive, which was created by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). Bharat Biotech was granted permission to conduct a Phase 2/3 clinical trial of Covaxin in children aged 2 to 18 years old earlier this month.

Nagaon , Maharashtra , India , Patna , Bihar , Delhi , Hyderabad , Andhra-pradesh , Nagpur , Bharat , Indian-council-of-medical-research

Covid-19: DCGI approves phase 2, 3 clinical trials of Covaxin on children aged 2 to 18 years | India News

Kolkata: A medic shows a vial containing doses of Covaxin during a Covid-19 vaccination drive at a government hospital, in Kolkata. (PTI)
NEW DELHI: The Drugs Controller General of India (DCGI) approved phase 2 and 3 clinical trial of Bharat Biotech's Covaxin vaccine in the age group of 2 to 18 years, the ministry of health and family welfare informed on Thursday.
"The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (Covid vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on May 12, 2021," the ministry said.

India , Bharat , Covaxin-covid , National-regulator , National-institute-of-virology , Indian-council-of-medical-research , Expert-committee , Bharat-biotech-ltd-on , Drugs-controller-general , Bharat-biotech , Subject-expert-committee , Bharat-biotech-ltd